WALTHAM, Mass., May 29, 2012 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a late-stage oncology company, announced today that updated

LONDON, May 28, 2012 /PRNewswire/ -- THIS RELEASE IS INTENDED EXCLUSIVELY FOR EUROPEAN MEDIA Data presented today from the VOYAGER study demonstrate the benefits

BASEL, Switzerland, May 25, 2012 /PRNewswire/ -- As announced today, Syngenta and attorneys for several community water systems have agreed to settle litigation related to the herbicide atrazine

BASEL, Switzerland and ST.

In April 2012, MHRA published an article revealing that there is recent epidemiological evidence of an increased risk of fracture with long-term use of PPIs (Proton Pump Inhibitors), including